HOME >> MEDICINE >> NEWS
Experts highlight cardiovascular and drug interaction risks in elderly patients

Boston, MA (September 30, 2002) Delegates attending the 7th International Conference on Geriatric Oncology reviewed data on the special treatment needs of elderly cancer patients. The data is relevant given the increased organ impairment (e.g. increased cardiovascular disease), and the increasing trend for multiple drug consumption ("poly-pharmacy") in the elderly cancer patient. Clinical trial experts say the potential risks to the elderly patient are underestimated due to restrictive clinical trial entry requirements.

Use of granisetron, an antiemetic drug with no cardiovascular restrictions and low potential for drug interactions is an appropriate choice for elderly cancer patients because granisetron is unlikely to create additional complications.

Antiemetics are used to treat chemotherapy and radiation therapy induced nausea and vomiting. Of the antiemetics, the 5HT3 receptor antagonists, like granisetron, are considered the gold standard in treatment and have a good tolerability and safety profile, particularly when compared to the other older antiemetics.

Differences, however, have been noted within the 5HT3 class in relation to the potential for cardiovascular toxicity and potential for adverse drug interactions.

Commenting on the cardiovascular risks from antiemetic therapy, Dr. Matti Aapro (Clinique de Genolier, Genolier, Switzerland) said, "The increased incidence of cardiovascular disease seen with increasing age necessitates careful consideration of the potential cardiotoxic properties of treatments."

"The increased risk from repeat cardiovascular insult in elderly patients with cardiovascular impairment is unknown, but the risk likely exists," said Dr. Aapro regarding clinical implications. "The cardiovascular side effect profile of antiemetics should be a key consideration in the elderly population and clinicians should be selecting the antiemetic with the lowest risk potential," he added.


'"/>

Contact: Whitney Hartmann
whitney.hartmann@shirehealthnewyork.com
212-725-7522
Shire Health New York
30-Sep-2002


Page: 1 2

Related medicine news :

1. Experts debate benefits, dangers of chlorine in C&EN point-counterpoint
2. Experts to discuss new advances in IBS therapy and its affect on IBS sufferers
3. Experts to discuss emerging technologies in GI diagnosis and treatment
4. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
5. Experts present new research on the hot topics of aging at GSAs Annual Meeting
6. Experts welcome major reforms to the coroners service
7. Experts meet to challenge approaches of testing and developing cancer treatments
8. Experts gathering to discuss tapping into $40-$50 billion natural products market
9. Experts recommend increased funding, focus on resuscitation science
10. Experts announce global antimicrobial resistance initiative - World preview of the Global White Paper on bacterial resistance in respiratory tract infections - a call for concerted international action
11. Heart Experts Call For Action Against Missed Opportunities To Prevent Heart Disease In Women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... ... framework agreements with China Resources Microelectronics Limited (CR Micro) and China Resources ... the possibility of establishing two joint research centres for novel micro-electronic devices ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) have elected Edward D. Buckingham, ... in the specialty field of facial plastics and reconstruction, while AAFPRS is an ...
(Date:11/15/2018)... ... 15, 2018 , ... Over the last decade, SABRE , the global ... for National Breast Cancer Foundation (NBCF) . A mission-driven organization and proud partner ... proceeds have helped launch the National Mammography Program which has provided almost ...
(Date:11/15/2018)... ... November 15, 2018 , ... ApriaDirect, ... now accepts Flexible Spending Account (FSA) and Health Savings Account (HSA) debit cards ... burden of healthcare spending for customers and improve the overall shopping experience. ...
(Date:11/15/2018)... ... November 15, 2018 , ... The National Cancer Institute estimates that 1.7 million ... primary risk factor for cancer and we typically associate the disease with old age, ... And with aggressive treatment and advanced therapies, increasing numbers of these patients survive their ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 16, 2018 , ... Drake’s Organic Spirits ... Certification by the globally-recognized and respected Vegan Awareness Foundation. Drake’s is the ... Vegan, Non-GMO Project Verified, Gluten-Free and Kosher. , Many consumers assume ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... Ric Henry, ... Health Care Center in Truth or Consequences, New Mexico on Friday, November 2, 2018. ... President of the Center’s Board of Directors. , Sierra Health Care Center has ...
(Date:11/15/2018)... ... November 15, 2018 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that Pete Young, Director of ... Partnerships in Clinical Trials (PCT) conference at the CCIB Convention Centre Barcelona, Barcelona, ...
Breaking Medicine Technology:
Cached News: